UK biotech OMass Therapeutics has revealed its first major pharma partnership, with Roche's Genentech unit paying $20 million upfront to tap into its expertise and find small-molecule therapies for ...
Already have a science or health-related degree? Fast-track your MBBS at a world-class University. Fascinated by the human body? Driven to shape the future of healthcare? Ready to make a difference to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback